hyaluronoglucosaminidase has been researched along with Kahler Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Bunting, S; Chaulagain, CP; Landau, KS; Saba, L | 1 |
| Iida, S; Kosugi, H; Matsumoto, M; Shibayama, H; Shibayama, K; Yamazaki, H | 1 |
| Hawley, RG; Kodaka, M; Okada, T; Okuno, H | 1 |
| Damade, R; Guechot, J; Laudat, A; Lecourbe, K; Palluel, AM | 1 |
| Glimelius, B; Nilsson, K; Pontén, J | 1 |
| Kjems, E; Mansa, B; Videbaek, A | 1 |
| Lindahl, U; Pontén, J; Wasteson, A; Westermark, B | 1 |
1 trial(s) available for hyaluronoglucosaminidase and Kahler Disease
| Article | Year |
|---|---|
Subcutaneous delivery of daratumumab in Japanese patients with relapsed/refractory multiple myeloma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents; Asian People; Cell Adhesion Molecules; Drug Compounding; Drug Delivery Systems; Humans; Hyaluronoglucosaminidase; Injections, Subcutaneous; Middle Aged; Multiple Myeloma; Recurrence; Safety; Treatment Outcome | 2021 |
6 other study(ies) available for hyaluronoglucosaminidase and Kahler Disease
| Article | Year |
|---|---|
Secondary Pure Red Cell Aplasia During Daratumumab/ Hyaluronidase Therapy for Multiple Myeloma.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Humans; Hyaluronoglucosaminidase; Multiple Myeloma; Red-Cell Aplasia, Pure | 2023 |
Significance of VLA-4-VCAM-1 interaction and CD44 for transendothelial invasion in a bone marrow metastatic myeloma model.
Topics: Animals; Antibodies, Monoclonal; Bone Marrow; Bone Marrow Cells; Cell Adhesion; Cell Line; Coculture Techniques; Endothelium; Female; Hyaluronan Receptors; Hyaluronic Acid; Hyaluronoglucosaminidase; Integrin alpha4beta1; Integrins; Mice; Mice, Inbred BALB C; Multiple Myeloma; Neoplasm Invasiveness; Neoplasm Proteins; Receptors, Lymphocyte Homing; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 1999 |
Hyaluronidase activity in serum of patients with monoclonal gammapathy.
Topics: Aged; Female; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Male; Multiple Myeloma; Waldenstrom Macroglobulinemia | 2000 |
Lectin agglutinability of non-neoplastic and neoplastic human lymphoid cells in vitro.
Topics: Agglutination; Cell Line; Concanavalin A; Humans; Hyaluronoglucosaminidase; Lectins; Leukemia; Lymphocyte Activation; Lymphocytes; Lymphoma; Multiple Myeloma; Neoplasms; Neuraminidase; Plant Lectins; Plants, Toxic; Ricinus; Stimulation, Chemical; Trypsin | 1975 |
A human IgA-myeloma protein with anti-streptococcal hyaluronidase (ASH) activity.
Topics: Antibodies, Bacterial; Binding Sites, Antibody; Bone Marrow; Bone Marrow Cells; Female; Humans; Hyaluronoglucosaminidase; Immunodiffusion; Immunoelectrophoresis; Immunoglobulin A; Immunoglobulin Fab Fragments; Melphalan; Middle Aged; Multiple Myeloma; Myeloma Proteins; Prednisone; Saliva | 1973 |
Aggregation of feline lymphoma cells by hyaluronic acid.
Topics: Animals; Antigen-Antibody Reactions; Burkitt Lymphoma; Cats; Cell Aggregation; Cell Line; Cell Membrane; Cells, Cultured; Chromatography, DEAE-Cellulose; Chromatography, Ion Exchange; Culture Media; Cytotoxicity Tests, Immunologic; Glioma; Glycosaminoglycans; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Lyases; Lymphoma; Lymphoma, Non-Hodgkin; Multiple Myeloma; Neoplasms, Experimental; Receptors, Drug; Sarcoma, Synovial; Time Factors; Trypsin | 1973 |